FINANCIAL RESULTS
2022-02-04LL

Fourth quarter and full year 2021 results

Fourth quarter and full-year 2021 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.

Featuring

  • Paul Hudson
    Chief Executive Officer
  • Jean-Baptiste de Chatillon
    Chief Financial Officer
  • Bill Sibold
    Specialty Care
  • Thomas Triomphe
    Vaccines
  • Olivier Charmeil
    General Medicines
  • Julie van Ongevalle
    Consumer Healthcare
  • John Reed
    R&D
  • Roy Papatheodorou
    General Counsel

Highlights

"Our performance in 2021 was impressive, across the business and in our scientific results. We are poised for success ahead."

Paul Hudson, CEO at Sanofi